等待开盘 08-14 09:30:00 美东时间
-0.750
-1.67%
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Canaccord Genuity raised the price target for LYFT Inc (NASDAQ:LYFT) from $15 to $16. Canaccord Genuity analys...
08-10 20:23
Stifel analyst Brian Brophy maintains Limbach Holdings (NASDAQ:LMB) with a Buy and lowers the price target from $107 to $86.
08-10 20:04
华盛资讯8月5日讯,Limbach公布2026财年Q2业绩,公司Q2营收1.73亿美元,同比增长21.9%,归母净利润0.05亿美元,同比下滑38.9%。
08-05 07:20
华盛资讯8月5日讯,Limbach公布2026财年Q2业绩,公司Q2营收1.73亿美元,同比增长21.9%,归母净利润0.05亿美元,同比下滑38.8%。
08-05 06:20
Limbach Holdings, Inc. (Nasdaq: LMB) ("Limbach," or the "Company"), a building systems solutions firm that partners with building owners and operators of mission-critical mechanical, electrical, plumbing, and controls ("MEPC") infrastructure, today announced that it has acquired CYMCOR, Inc. ("CYMCO...
08-05 04:37
Limbach Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-05 04:34
Limbach Holdings (LMB) on Tuesday said it has acquired CYMCOR for a purchase price of $30 million. Limbach said the transaction was funded through a combination of cash on hand and borrowings under th...
08-05 04:26
Limbach Holdings (NASDAQ:LMB) raises FY2026 sales outlook from $730.000 million-$760.000 million to $760.000 million-$790.000 million vs $743.564 million estimate.
08-05 04:25
Limbach Holdings (NASDAQ:LMB) reported quarterly earnings of $0.64 per share which missed the analyst consensus estimate of $0.72 by 11.11 percent. This is a 31.18 percent decrease over earnings of $0.93 per share from the same period last year. The company reported quarterly sales of $173.457 milli...
08-05 04:22